51成人动漫

Nephrology

News, opinions and meeting coverage in nephrology.

ECC Roundup: Breast Conservation Benefit Varies by Age

And other reports from the European Cancer Congress

Subclavian TAVR Safe When Femoral Access Is Risky

Trial analysis shows similar morbidity, mortality

SAVR Beats Expectations in Intermediate Risk Trial

Lower mortality than surgical risk score predicted in PARTNER 2A

FDA Warns on MRI in Patients with Implantable Pumps

Medication, mechanical issues may follow exposure

Novartis Pulls Out of Controversial Entresto Contest

Cardiologists named to review panel had quit

Nephrology Training Programs a Hard Sell

Pay, lifestyle issues may hamper interest in the specialty

Amyloidosis Treatments Miss the Heart of the Problem

Only modest improvement in end organ function

CMS to Offer Billing Code for Heart Failure Specialists

Should eliminate denials for appearance of double-billing

Oral Treatment for T2D Tied to Renal Protection

SGLT2 inhibitor shows favorable effect on eGFR

Quick Steroid Withdrawal Works in Post-Transplant Diabetes

Incidence dropped from 39% to about 24%

Opioid Rx Linked to Higher Mortality in Dialysis Patients

Risks for hospitalization, dialysis discontinuation also higher

Lowering Urate Helps Renal Function

Most improvement seen in stage 3 chronic kidney disease

New Hospital Care Model Cut Readmissions, Boosted Satisfaction

Specialists urged to reconnect with generalist roots

Nephrologists at Kidney Week Blast Recertification Process

Consensus: stop making it a high-stakes exam

Trial: No Benefit for High-Dose Diuretic in Acute HF

But phase II results might not be the final word

AHA: No Pump Thrombosis With Next-Gen LVAD?

Better outcomes in HeartMate 3 trial hinged on fewer malfunctions

AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

Investigational drug ularitide had no effect on mortality or clinical outcomes

TCT: TAVR Holds Up Pretty Well Over Time

Also, 2-year data confirm lasting improvements in QoL

TCT: Embolic Protection Flops for TAVR

New brain lesions or clinical strokes unaffected in SENTINEL trial

CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

U.S. Obesity Crisis: Is the Wrong Omega-X Mix Responsible?

Ratio of omega-6 to omega-3 in Western diet is 16:1

Pearls From: Roxana Mehran, MD

Interventional cardiologist discusses acute kidney injury reduction

Slow Medicine: Is 'Hypertensive Urgency' Outdated?

No need to over-react to a common dx that's not tied to major CV events

HFSA: Clinical Benefits Tied To Lung Monitoring Persist

HF rehospitalization, deaths remain reduced up to 4.5 years

Cardiac Myosin Activator Shows Promise for LV Function

'More hands pulling on the rope'

HFSA: Treat to NT-proBNP Target Flops in Trial

Outcomes no better with treatment aimed at 30% reduction

HFSA: Did LAP Monitoring Cut HF Rehospitalizations?

LAPTOP-HF investigators tried to make sense of terminated study

Longer-Term Home Use Safe for Artificial Pancreas System

3-month study might pave way to FDA clearance

Switching GLP-1 For DPP-4 Improves Net T2D Outcomes

Victoza bests Januvia for combo therapy on A1c, weight, hypoglycemia composite

How Sweet: Sugar Industry Made Fat the Villain

Harvard researchers received sugar industry money to write a NEJMreview

MedPAC Looks at Ways to Adjust Misvalued Services

Commission debates grouping CPT codes into families

CardioBrief: Cardiologists Give SPRINT Thumbs Down

Trial should not be used in guidelines to lower blood pressure targets

ESC: No Mortality Benefit With ICD in Nonischemic HF

Eleven fewer deaths over 5 years

Is 2018 the Year of the Bionic Pancreas?

Two experts review the state of closed-loop systems for type 1 diabetes

FDA Panel Splits on Expanded Jardiance Indication

Questions raised about key trial

Are Expensive Diabetes Drugs Worth It?

Jardiance and Victoza improve hard outcomes, but at a hefty cost

301 People Charged With $900 Million in False Medicare Billings

Largest sweep since government fraud team began in 2007

Mixed Findings on High Birth Weight, CV Risk Factors

Some markers of cardiovascular health better with high birth weight

Jardiance Shows Renal Benefit in EMPA-REG

Diabetes drug linked to slowing of kidney disease progression

鈥�

36

鈥�